Menu Close

About
Team
Services
- Total Wealth Management
- Exclusive Family Office
Stories
Resources
- All Resources
- Fathom Blog
- Podcast
- Ebooks
- Videos
Login

Login

Talk to us (415) 371–7800

Our People

Pages

Fathom Blog

Resources

Aspiriant News

Andy Putterman

Independent Director, Member of Board of Directors

Colleagues

Next Up

Our Services

Entering a world brimming with warmth and expertise.

Sign up for updates:

About

Overview
Our Story
Locations
FAQ
Awards & Press
Diversity, Inclusion & Belonging
Careers
Partner With Us

Team

Our Exceptional People
Leadership
Partners
Advisors
Investment Team
Distinguished Alums
Board of Directors

Services

Total Wealth Management
Exclusive Family Office

Learn

Fathom Blog
Podcast
Ebooks
Videos

Stories

Multi-Family Office
Optimizing Equity Compensation
Navigating Liquidity Events
Fiduciaries
Family Business Owners
Women Taking Charge

Locations

Los Angeles
San Francisco
Austin
Cincinnati
Milwaukee
Minneapolis
New York
Orange County
San Diego
Silicon Valley

©2026 Aspiriant, LLC

Privacy Rights and Policies Information Sharing Terms of Use Accessibility Form CRS Form ADV

Disclosure: The above represents the views and opinions of Aspiriant and is not the result of fact based analysis but is the result of the impressions we receive when dealing with some of our clients and our competitors. There is no guarantee of success and that investing in securities involves the risk of a part or total loss of investment which investors should be prepared to bear.

Aspiriant is a registered investment adviser with the United States Securities and Exchange Commission (“SEC”). For additional information regarding our registration with the SEC, please click on the link below identified as ADV. For a copy of our full ADV filed with the SEC, please click on the following SEC public disclosure consumer website: ASPIRIANT, LLC – Investment Adviser Firm (sec.gov). Please note that registration with the SEC does not suggest a certain level of skill and training. We also urge to you view Form CRS above, which Aspiriant is required to provide to all retail investors.

By clicking “Submit”, you acknowledge that we collect your name, email address and phone number to respond to your inquiries and provide you information about our products and services in accordance with our Privacy Policy. If you are a California resident, please see our CCPA Notice to California Residents.